Thomas Pollare

All filings by Thomas Pollare on record concern AlzeCure Pharma AB, in the capacity of board member. We count 2 filings; the first trade dates from 23 July 2025 and the latest from 30 June 2026.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The record was last updated on 1 July 2026 with a transaction (€28k) in AlzeCure Pharma AB. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.